Canadian cannabis removal business, MediPharm laboratories Corp. has announced they own been chosen because of the Mount Sinai Hospital in new york to be involved in a clinical trial concentrated on developing a non-addictive cannabidiol (CBD) gelcap for the treatment opioid addiction.
MediPharm will produce the gelcap utilizing a proprietary hemp-derived CBD formula from certified cannabis that are jamaican, Timeless Herbal Care Inc.
Dr. Yasmin Hurd of Mount Sinai claims which they selected MediPharm as a result of The quality of the ongoing company’s products and their experience with pharmaceutical and research that is clinical. (mehr …)